Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure.
暂无分享,去创建一个
G. Stiegler | J. Stadlmann | H. Steinkellner | M. Pabst | R. Strasser | J. Glössl | K. Weterings | L. Mach | Matthias Schähs | Heribert Quendler
[1] K. Shitara,et al. The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity* , 2003, The Journal of Biological Chemistry.
[2] David Passmore,et al. Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor , 2006, Nature Biotechnology.
[3] R. Kunert,et al. Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. , 2007, Plant biotechnology journal.
[4] A. Trkola,et al. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 , 1996, Journal of virology.
[5] F. Altmann,et al. Unaltered complex N-glycan profiles in Nicotiana benthamiana despite drastic reduction of β1,2-N-acetylglucosaminyltransferase I activity , 2004, Glycoconjugate Journal.
[6] M. Van Montagu,et al. Aberrant localization and underglycosylation of highly accumulating single-chain Fv-Fc antibodies in transgenic Arabidopsis seeds , 2007, Proceedings of the National Academy of Sciences.
[7] H. Katinger,et al. Functional analysis of the broadly neutralizing human anti‐HIV‐1 antibody 2F5 produced in transgenic BY‐2 suspension cultures , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] H. Steinkellner,et al. Generation of Arabidopsis thaliana plants with complex N‐glycans lacking β1,2‐linked xylose and core α1,3‐linked fucose , 2004 .
[9] C. Stemmer,et al. In vivo glyco‐engineered antibody with improved lytic potential produced by an innovative non‐mammalian expression system , 2007, Biotechnology journal.
[10] S. Marillonnet,et al. In planta engineering of viral RNA replicons: efficient assembly by recombination of DNA modules delivered by Agrobacterium. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Van Montagu,et al. High level accumulation of single-chain variable fragments in the cytosol of transgenic Petunia hybrida. , 1999, European journal of biochemistry.
[12] A. Trkola,et al. Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies , 2005, Nature Medicine.
[13] I. Wilson,et al. Structural analysis of N-glycans from allergenic grass, ragweed and tree pollens: Core α1,3-linked fucose and xylose present in all pollens examined , 1998, Glycoconjugate Journal.
[14] P. Christou,et al. Plantibodies: applications, advantages and bottlenecks. , 2002, Current opinion in biotechnology.
[15] L. Presta,et al. Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* , 2002, The Journal of Biological Chemistry.
[16] F. Altmann. The Role of Protein Glycosylation in Allergy , 2006, International Archives of Allergy and Immunology.
[17] Carola Engler,et al. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors , 2006, Proceedings of the National Academy of Sciences.
[18] P. Lerouge,et al. N-Glycosylation of a mouse IgG expressed in transgenic tobacco plants. , 1999, Glycobiology.
[19] H. Katinger,et al. A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1 , 2002, AIDS.
[20] L. Reed,et al. A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .
[21] F. Altmann,et al. Molecular cloning and heterologous expression of beta1,2-xylosyltransferase and core alpha1,3-fucosyltransferase from maize. , 2006, Phytochemistry.
[22] R. Twyman,et al. Antibody production in transgenic plants. , 2004, Methods in molecular biology.
[23] P. Lerouge,et al. Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glyco-engineering into human-compatible structures. , 2003, Plant biotechnology journal.
[24] P. Umaña,et al. The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. , 2006, The Journal of biological chemistry.
[25] P. Lerouge,et al. Galactose-extended glycans of antibodies produced by transgenic plants , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Stadlmann,et al. A Unique β1,3-Galactosyltransferase Is Indispensable for the Biosynthesis of N-Glycans Containing Lewis a Structures in Arabidopsis thaliana[W][OA] , 2007, The Plant Cell Online.